Original Research
International Journal of Impotence Research (2005) 17, 76–79. doi:10.1038/sj.ijir.3901265 Published online 21 October 2004
Evaluation of sexual activity in patients treated with tadalafil: a randomized prospective placebo-controlled trial
A F De Rose1, F Gallo1 and G Carmignani1
1Department of Urology, S Martino's Hospital, University of Genoa, Genoa, Italy
Correspondence: AF De Rose, Department of Urology, S Martino's Hospital, University of Genoa, Via Donato Somma 77/9, Genova, Italy. E-mail: aldofdr@libero.it
Received 17 March 2004; Revised 9 July 2004; Accepted 29 August 2004; Published online 21 October 2004.
Abstract
The chronological distribution of sexual intercourses in a group of patients treated with tadalafil versus placebo for 3 months was evaluated. In total, 120 patients with ED were randomized in two groups and treated, respectively, with one pill of tadalafil 20 mg or placebo on Tuesday and on Friday. After 3 months, we collected data using IIEF and SEP diaries. After 3 months, IIEF score and percentages of success SEP diaries increased in the tadalafil group (<0.01) versus placebo group. Considering all the successful intercourses of the 3 months of tadalafil assumption, the highest percentages were reported within 6–12 h range (35%) and 12–24 h range (28%). In tadalafil group, 41% of patients reported their first successful intercourse between 1 and 6 h and 78% of patients reported the recovery of spontaneous erections. In conclusion, after carrying out the first sexual attempt between 1 and 6 h, patients engaged in sexual activity between 6 and 24 h.
Keywords:
penile erection, impotence, erectile dysfunction, drug therapy, phosphodiesterase inhibitors
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Nature Medicine News and Views (01 Mar 2000)
